Jason Hinton, MD
Radiation Oncology · Muncie, INNPI 1609138395
Payments from drug & device makers
Across 30 payments — averaging $17.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$144
- Merck$57
- AstraZeneca$48
- Genmab U.S., Inc.$30
- Taiho Oncology, Inc.$27
- Sanofi$26
- plus $201 from 12 others
What the payments were for
- Food & beverage$533100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 8 | $144 |
| Merck | 3 | $57 |
| AstraZeneca(2 entities) | 3 | $48 |
| Genmab U.S., Inc. | 2 | $30 |
| Taiho Oncology, Inc. | 1 | $27 |
| Sanofi | 1 | $26 |
| Siemens Medical Solutions USA, Inc. | 1 | $23 |
| Adaptive Biotechnologies Corporation | 1 | $23 |
| Accord Healthcare, Inc. | 1 | $19 |
| Eisai Inc. | 1 | $17 |
| Bayer | 1 | $17 |
| Beigene USA, Inc. | 1 | $17 |
| AbbVie | 1 | $17 |
| Beone Medicines USA, Inc. | 1 | $16 |
| Boston Scientific | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Deciphera Pharmaceuticals Inc. | 1 | $14 |
| Clovis Oncology, Inc. | 1 | $8 |
How this compares
$533 in reported general payments places this provider in the 45th percentile of 116 radiation oncology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl | 20 | $1,536 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $482 |
| Silver Sulfadiazine | 11 | $254 |
| Tamsulosin Hcl | 37 | $238 |
| Lidocaine Hcl ViscousLidocaine Hcl | 15 | $122 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Muncie
- Anthony TilmansMuncie$4K
- Brian ChangFort Wayne$1.8M
- Michael EatonIndianapolis$950K
- William PorterMadison$395K
- Charles VuFort Wayne$58K
- James WheelerGoshen$30K
- Higinia CardenesIndianapolis$24K
- Houman VaghefiGoshen$9K
- Binh TranMishawaka$7K
- Gordon WatsonIndianapolis$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.